ARCHIVES

Phase II Imbruvica Trial Shows 47% of MCL Patients Alive at 27-Month Median Follow-up

This article is from The Cancer Letter archive.

Vol. 37 No. 12 | December 26, 2014

Download PDF Visit The Full Archive

Related Articles

Jako Bows Out with Blast At NCI, Calls For IOM Review Of Cancer Program

April 15, 1988

DCT Advisors OK Recompetition Of Drug Contacts

March 15, 1991

NCAB Says Restrictions on Animal Research Threatens Progress

May 20, 1988

Waksal Pleads Guilty To Securities Fraud

October 18, 2002

Scientific Process

September 25, 1998

NCI Review Groups Merged Into One Umbrella Group

November 17, 1995